PT

Protagonist Therapeutics

PTGX
NASDAQHealth Care

Income Statement

Total Revenue$434.43M
Gross Profit$434.43M
Operating Income$252.84M
EBITDA$282.3M
EBIT$279.41M
Pre-tax Income$-115.38M
Net Income$275.19M

Balance Sheet

Cash Equivalent$189.15M
Total Debt$8.3M
Book Value$577.24M
Book Value Per Share9.81

Key Ratios

Return on Equity (ROE)+40.75%
Return on Assets (ROA)+36.95%
Return on Invested Capital (ROI)+40.75%
Net Profit Margin+63.34%
Current Ratio12.48
Quick Ratio12.39
Long-Term Debt / Equity0.00